New ALS pill enters human testing
Disease control
Not yet recruiting
This early-stage trial is testing an oral medication called NB-4746 in people with ALS (amyotrophic lateral sclerosis). The main goals are to check the drug's safety, see how the body processes it, and measure if it affects a blood marker of nerve damage. About 80 participants wi…
Phase: PHASE1, PHASE2 • Sponsor: Nura Bio • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC